American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, rev. APA, Washington, DC
Google Scholar
CPMP Working Party on Efficacy of Medicinal Products (1992) Antidementia medicinal products. Note for guidance (Draft 5). Commission of the European Communities, Brussels
Google Scholar
Erzigkeit H (1989) SKT: Ein Kurztest zur Erfassung von Gedächtnis- und Aufmerksamkeitsstörungen (4th ed.) [SKT: A short test to assess impairment of memory and attention]. Beltz Test, Weinheim
Google Scholar
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198
Article
PubMed
CAS
Google Scholar
Gutzmann H, Hadler D, Erzigkeit H (1997) Long-term treatment of Alzheimer’s disease with idebenone. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewki HM (eds) Alzheimer’s disease: biology, diagnosis and therapeutics. John Wiley & Sons, New York, pp 687–705
Google Scholar
Hachinski VC, Illiff LD, Zihlka E, DuBoulay GH, McAllister VL, Marshall R, Ross-Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637
Article
PubMed
CAS
Google Scholar
Kanowski S, Ladurner G, Maurer K, Oswald WD, Stein U (1990) Empfehlungen zur Evaluierung der Wirksamkeit von Nootropika. Z Gerontopsychol-psychiatr 3: 67–79
Google Scholar
Kern U, Menges K (1992) Proof of efficacy of nootropics for the indication “dementia” (Phase III) — Recommendations. Pharmacopsychiatry 25: 126–135
Article
Google Scholar
Leber P (1996) Observations and suggestions on antidementia drug development. Alzheimer Dis Assoc Disord 10 [Suppl 1]: 31–35
Article
PubMed
Google Scholar
Lienert GA (1967) Testaufbau und Testanalyse, 2nd ed. [Test construction and test analysis]. Beltz, Weinheim
Google Scholar
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department Health & Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944
Article
PubMed
CAS
Google Scholar
National Institute of Mental Health (1976) Clinical Global Impressions. In: Guy W (ed) EDCEU assessment manual for psychopharmacology, rev ed. NIMH, Rockville, MD, pp 217–222
Google Scholar
Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry 141: 1356–1364
PubMed
CAS
Google Scholar
Sano M, et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 336: 1216–1222
Article
PubMed
CAS
Google Scholar
Senin U, Parnetti L, Barbagallo-Sangiorgi G, Bartorelli L, Bocola V, Capurso A, Cuzzupoli M, Denario M, Marigliano V, Tammaro A, Fioravanti M (1992) Idebenone in senile dementia of Alzheimer type: a multicentre study. Arch Gerontol Geriatr 15: 249–260
Article
PubMed
CAS
Google Scholar
Spiegel R, Brunner C, Ermini-Fünfschilling D, Monsch A, Notter M, Puxty J, Tremmel L (1991) A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses’ Observation Scale for Geriatric Patients). J Am Geriatr Soc 39: 339–347
PubMed
CAS
Google Scholar
Weyer G, Ihl R, Mohs RC, Schambach M, Denkel A, Kaiser-Kehl H (1993) Validierungsuntersuchungen zu einer deutschen Version der Alzheimer’s Disease Assessment Scale ADAS [Investigations on the validity of a German version of the Alzheimer’s Disease Assessment Scale ADAS]. Z Gerontopsychol-psychiatr 6: 67–81
Google Scholar
Weyer G, Erzigkeit H, Hadler D, Kubicki S (1996) Efficacy and safety of idebenone in the long-term treatment of Alzheimer’s disease: a double-blind, placebo-controlled multicentre study. Hum Psychopharmacol 11: 53–65
Article
CAS
Google Scholar
Weyer G, Babej-Dölle RM, Hadler D, Hofmann S, Herrmann W (1997) A controlled study of 2 doses of idebenone in the treatment of Alzheimer’s disease. Neuropsychobiology 11: 340–350
Google Scholar
World Medical Association (1989) Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects (Amended by the 41st World Medical Assembly, Hong Kong, September 1989)
Google Scholar